B&A Therapeutics

Quick facts

Phase 2 pipeline

• Bumetanide white, oblong, scored tablet · Cardiovascular
  Inhibits the Na-K-2Cl cotransporter 2 (NKCC2) in the thick ascending limb of the loop of Henle.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• B&A Therapeutics portfolio CI brief
• B&A Therapeutics pipeline updates RSS

Related

• Sector hub: All tracked pharma companies